{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:21:52Z","timestamp":1787844112001,"version":"build-2784847793"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of the study is to present our experience of treating adrenal metastases using stereotactic body radiation therapy (SBRT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We retrospectively reviewed patients with adrenal metastases treated using SBRT from 2001 to 2014. Response Evaluation Criteria in Solid Tumors v1.1 was used. Maximum tumor response was defined as the greatest percentage tumor reduction noted on two or more post-SBRT CT scans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We identified 44 patients (median age 61.3 years, range: 25.8\u201385), with 54 adrenal metastases; primary diagnoses include non-small cell lung cancer (28 patients and 38 lesions), small cell lung cancer (1 patient), hepatocellular carcinoma (6 patients), and other (9 patients). Treatment was delivered in single (16 lesions, median dose 18 Gy [14\u201318]) or multiple fractions (38 lesions, median dose 30 Gy [16\u201340]). Median planning target volume was 49.65cc (3.21\u2013984.54). Median response at first post-SBRT follow-up (median 1.65 months (m) (0.33\u20135.37),\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 46 lesions) was 10.8% with 91.3% local control. Median maximum tumor response was 31.8% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 32 lesions) at median follow-up of 5.4 m (0.9\u201344.8) with 96.6% local control. The response was comparable regardless of tumor histology or treatment fractionation. No patients experienced Grade 3\/4 acute toxicities. One patient with a history of naproxen use required suturing with omental patch placement for perforated pyloric ulcer 14 m post-SBRT (18 Gy in single fraction) to the right adrenal metastasis; this region received &lt;5 Gy. Ten patients treated for pain with available follow-up obtained relief.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>SBRT is a safe and efficacious treatment for adrenal metastases, demonstrating local tumor control. Further study of the impact on survival and quality of life is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_655_16","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T03:25:15Z","timestamp":1539746715000},"page":"S27-S32","source":"Crossref","is-referenced-by-count":16,"title":["Single institution experience treating adrenal metastases with stereotactic body radiation therapy"],"prefix":"10.4103","volume":"15","author":[{"given":"Mira Mahendra","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Isrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Fareed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther","family":"Ajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20231106","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11934-009-0012-0","article-title":"Surgical management of metastases to the adrenal gland: Open, laparoscopic, and ablative approaches","volume":"10","author":"Uberoi","year":"2009","journal-title":"Curr Urol Rep"},{"key":"R2-4-20231106","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","article-title":"Metastases in carcinoma; Analysis of 1000 autopsied cases","volume":"3","author":"Abrams","year":"1950","journal-title":"Cancer"},{"key":"R3-4-20231106","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/crad.2002.1054","article-title":"Predictive value of benign percutaneous adrenal biopsies in oncology patients","volume":"57","author":"Harisinghani","year":"2002","journal-title":"Clin Radiol"},{"key":"R4-4-20231106","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejso.2010.04.002","article-title":"Prognostic factors for survival after surgery for adrenal metastasis","volume":"36","author":"Muth","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R5-4-20231106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(19900101)65:1<177::AID-CNCR2820650134>3.0.CO;2-8","article-title":"Addisonian crisis as presenting feature in malignancies","volume":"65","author":"Kung","year":"1990","journal-title":"Cancer"},{"key":"R6-4-20231106","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","article-title":"Stereotactic body radiotherapy for treatment of adrenal metastases","volume":"75","author":"Chawla","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-4-20231106","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer","volume":"45","author":"Kumar","year":"2004","journal-title":"J Nucl Med"},{"key":"R8-4-20231106","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","article-title":"Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients","volume":"51","author":"Scorsetti","year":"2012","journal-title":"Acta Oncol"},{"key":"R9-4-20231106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<395::AID-CNCR20>3.0.CO;2-T","article-title":"The role of surgery in the treatment of clinically isolated adrenal metastasis","volume":"82","author":"Kim","year":"1998","journal-title":"Cancer"},{"key":"R10-4-20231106","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: A systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"R11-4-20231106","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0003-4975(97)01284-8","article-title":"Adrenalectomy for a solitary adrenal metastasis from lung cancer","volume":"65","author":"Porte","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"R12-4-20231106","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0936-6555(96)80087-2","article-title":"Palliation of symptomatic adrenal gland metastases by radiotherapy","volume":"8","author":"Short","year":"1996","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"R13-4-20231106","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1245\/s10434-007-9520-7","article-title":"Laparoscopic adrenalectomy for isolated adrenal metastasis","volume":"14","author":"Strong","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R14-4-20231106","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cncr.11084","article-title":"Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases","volume":"97","author":"Wood","year":"2003","journal-title":"Cancer"},{"key":"R15-4-20231106","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","article-title":"Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer","volume":"187","author":"Holy","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"R16-4-20231106","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"R17-4-20231106","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R18-4-20231106","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1245\/s10434-007-9426-4","article-title":"Isolated adrenal mass in patients with a history of cancer: Remember pheochromocytoma","volume":"14","author":"Adler","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R19-4-20231106","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1097-0142(19900315)65:6<1318::AID-CNCR2820650611>3.0.CO;2-H","article-title":"Palliative radiotherapy for symptomatic adrenal metastases","volume":"65","author":"Soffen","year":"1990","journal-title":"Cancer"},{"key":"R20-4-20231106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jjco\/hyi020","article-title":"Radiation therapy for adrenal gland metastases from hepatocellular carcinoma","volume":"35","author":"Zeng","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"R21-4-20231106","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","article-title":"Review and uses of stereotactic body radiation therapy for oligometastases","volume":"17","author":"Alongi","year":"2012","journal-title":"Oncologist"},{"key":"R22-4-20231106","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1586\/era.12.125","article-title":"Stereotactic body radiation therapy for metastasis to the adrenal glands","volume":"12","author":"Shiue","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"R23-4-20231106","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2217\/fon.14.13","article-title":"Emerging applications of stereotactic body radiotherapy","volume":"10","author":"Lo","year":"2014","journal-title":"Future Oncol"},{"key":"R24-4-20231106","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","article-title":"Stereotactic radiotherapy for adrenal gland metastases: University of florence experience","volume":"82","author":"Casamassima","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-4-20231106","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","article-title":"Stereotactic body radiotherapy in the treatment of adrenal metastases","volume":"36","author":"Ahmed","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"R26-4-20231106","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/tj.5000222","article-title":"Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer","volume":"101","author":"Gamsiz","year":"2015","journal-title":"Tumori"},{"key":"R27-4-20231106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7785\/tcrt.2012.500320","article-title":"Stereotactic body radiation therapy for curative treatment of adrenal metastases","volume":"12","author":"Rudra","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"R28-4-20231106","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2008.03.013","article-title":"Real-time tumor-tracking radiotherapy for adrenal tumors","volume":"87","author":"Katoh","year":"2008","journal-title":"Radiother Oncol"},{"key":"R29-4-20231106","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(99)00413-7","article-title":"Extracranial stereotactic radiation therapy: Set-up accuracy of patients treated for liver metastases","volume":"46","author":"Herfarth","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R30-4-20231106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0167-8140(99)00037-7","article-title":"Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computed tomography and linear accelerator (focal) unit: Evaluation of z-axis with a z-marker","volume":"50","author":"Uematsu","year":"1999","journal-title":"Radiother Oncol"},{"key":"R31-4-20231106","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0167-8140(00)00226-7","article-title":"Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame","volume":"57","author":"Wulf","year":"2000","journal-title":"Radiother Oncol"},{"key":"R32-4-20231106","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ctrv.2014.04.001","article-title":"Surgical and ablative therapies for the management of adrenal 'oligometastases' \u2013 A systematic review","volume":"40","author":"Gunjur","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"R33-4-20231106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13566-012-0037-8","article-title":"Stereotactic body radiotherapy for adrenal metastases from lung cancer","volume":"1","author":"Guiou","year":"2012","journal-title":"J Radiat Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201915001-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:06:03Z","timestamp":1787843163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201915001-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_655_16","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}